Great Tree Pharmacy Co Ltd
Great Tree Pharmacy Co., Ltd. engages in management and trading of drugs, health supplements, maternity and infant products, and cosmetics products in Taiwan, Mainland China, and Malaysia. The company also provides coordinated medicine procurement services to various clinics, outpatient centers, medical communities. In addition, it engages in the wholesale and retail business and packaging and wa… Read more
Great Tree Pharmacy Co Ltd (6469) - Total Assets
Latest total assets as of December 2025: NT$13.76 Billion TWD
Based on the latest financial reports, Great Tree Pharmacy Co Ltd (6469) holds total assets worth NT$13.76 Billion TWD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Great Tree Pharmacy Co Ltd - Total Assets Trend (2012–2025)
This chart illustrates how Great Tree Pharmacy Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Great Tree Pharmacy Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Great Tree Pharmacy Co Ltd's total assets of NT$13.76 Billion consist of 54.4% current assets and 45.6% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 12.9% |
| Accounts Receivable | NT$659.26 Million | 4.8% |
| Inventory | NT$3.69 Billion | 26.8% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$85.73 Million | 0.6% |
| Goodwill | NT$0.00 | 0.0% |
Asset Composition Trend (2012–2025)
This chart illustrates how Great Tree Pharmacy Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Great Tree Pharmacy Co Ltd's current assets represent 54.4% of total assets in 2025, a decrease from 84.2% in 2012.
- Cash Position: Cash and equivalents constituted 12.9% of total assets in 2025, down from 24.7% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 26.8% of total assets.
Great Tree Pharmacy Co Ltd Competitors by Total Assets
Key competitors of Great Tree Pharmacy Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
Great Tree Pharmacy Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Great Tree Pharmacy Co Ltd generates 1.37x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Great Tree Pharmacy Co Ltd generates $ 4.36 in net profit.
Great Tree Pharmacy Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.63 | 1.38 | 1.29 |
| Quick Ratio | 0.83 | 0.71 | 0.58 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$2.89 Billion | NT$ 1.78 Billion | NT$ 635.23 Million |
Great Tree Pharmacy Co Ltd - Advanced Valuation Insights
This section examines the relationship between Great Tree Pharmacy Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.08 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 13.5% |
| Total Assets | NT$13.76 Billion |
| Market Capitalization | $205.37 Million USD |
Valuation Analysis
Below Book Valuation: The market values Great Tree Pharmacy Co Ltd's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Great Tree Pharmacy Co Ltd's assets grew by 13.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Great Tree Pharmacy Co Ltd (2012–2025)
The table below shows the annual total assets of Great Tree Pharmacy Co Ltd from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | NT$13.76 Billion | +13.46% |
| 2024-12-31 | NT$12.13 Billion | +12.57% |
| 2023-12-31 | NT$10.77 Billion | +6.47% |
| 2022-12-31 | NT$10.12 Billion | +36.92% |
| 2021-12-31 | NT$7.39 Billion | +22.97% |
| 2020-12-31 | NT$6.01 Billion | +28.46% |
| 2019-12-31 | NT$4.68 Billion | +102.88% |
| 2018-12-31 | NT$2.31 Billion | +50.01% |
| 2017-12-31 | NT$1.54 Billion | +20.10% |
| 2016-12-31 | NT$1.28 Billion | +47.30% |
| 2015-12-31 | NT$868.89 Million | +11.49% |
| 2014-12-31 | NT$779.34 Million | +75.37% |
| 2013-12-31 | NT$444.41 Million | +46.66% |
| 2012-12-31 | NT$303.03 Million | -- |